Abstract
To investigate whether brassinosteroids (BR) affects cytokinin (CK)-induced anthocyanin biosynthesis, seedlings of the Arabidopsis dwarf4 (dwf4) mutants including partially suppressing coi1 (psc1) and dwf4-102, which are defective in the BR biosynthesis, and the brassinosteroid-insensitive 1–4 (bri1-4) mutant defective in BR signalling were used for the analysis of CK-induced anthocyanin accumulation and the expression of anthocyanin biosynthetic genes and WD-repeat/Myb/bHLH transcription factors. The results show that the CK-induced anthocyanin accumulation was remarkably reduced in dwf4 and bri1-4 mutants, but distinctly increased in the wild type (WT) treated with BR. Moreover, the CK-induced expressions of the late anthocyanin biosynthetic genes including dihydroflavonol reductase, leucoanthocyanidin dioxygenase, and UDP-glucose: flavonoid-3-O-glucosyl transferase were significantly reduced in bri1-4 and dwf4-102 mutants compared to WT. In addition, the expressions of transcription factors production of anthocyanin pigment 1 (PAP1), glabra 3 (GL3), and enhancer of glabra 3 (EGL3) were induced by CK in WT but not in the bri1-4 and dwf4-102 mutants. These results indicate that BR enhanced the CK-induced anthocyanin biosynthesis by up-regulating the late anthocyanin biosynthetic genes and this regulation might be mediated by the transcription factors PAP1, GL3, and EGL3.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.